Physician profile
Justin Morrison
NPI 1326467010
$16,344.44
in general payments reported to CMS, 2019-2025
17 companies · $3,461 in 2025
The $3,461 reported for 2025 was more than what 77% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $250 · 2021: $156 · 2022: $1,680 · 2023: $759 · 2024: $10K · 2025: $3,461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,000 · Food and Beverage: $4,182 · Travel and Lodging: $2,202 · Consulting Fee: $1,875.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,000.00 |
| Food and Beverage | $4,182.00 |
| Travel and Lodging | $2,201.50 |
| Consulting Fee | $1,875.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $7,927.79 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $3,853.91 | 2023-2025 | Avvigo Guidance System, Eluvia, Rotapro |
| Edwards Lifesciences Corporation | $1,513.62 | 2022-2023 | Sapien 3 Ultra Resilia |
| Penumbra, INC. | $865.75 | 2023-2025 | Indigo System, Penumbra System |
| Medtronic, INC. | $632.28 | 2022-2025 | Endurant Iis, Ffrangio, Symplicity G3 |
| Abbott Laboratories | $440.92 | 2021-2025 | Diamondback Peripheral, Esprit |
| Philips North America LLC | $267.44 | 2023-2024 | (Dd3) Venous Stent Und |
| Medtronic Vascular, INC. | $249.99 | 2019 | |
| W. L. Gore & Associates, INC. | $128.66 | 2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Endologix LLC | $128.56 | 2025 | Torus Stent Graft System, Endocross Device |
| Amplitude Vascular Systems, INC. | $121.88 | 2024 | |
| Bard Peripheral Vascular, INC. | $81.95 | 2024 | Crosser Iq |
| Stryker Corporation | $55.36 | 2025 | Artix Mt |
| Novo Nordisk INC | $44.41 | 2025 | Wegovy |
| Biotronik INC. | $16.99 | 2023 | Nhancer Rx, Orsiro Mission, Pk Papyrus |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.93 | 2024 | Lifevest |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Morrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.